Details of the Drug
General Information of Drug (ID: DMJP5YF)
| Drug Name | 
                     Levodropropizine 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        Levodropropizine; 99291-25-5; (S)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; Levdropropizine; (-)-Dropropizine; Levotuss; Danka; Levodropropizina; Levodropropizinum; (2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol; Rapitux; UNII-3O31P6T4G3; Levodropropizinum [INN-Latin]; Levodropropizina [INN-Spanish]; 99291-24-4; Levodropropizine [INN]; DF 526; CHEBI:82722; 3O31P6T4G3; S(-)-3-(4-Phenylpiperazin-1-yl)propane-1,2-diol; (-)-(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol; Levodropropizine (INN); 1,2-Propanediol, 3-(4-phenyl-1-pipe
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| ATC Code | 
                    
                    
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||

